Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.
about
The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.The safety and efficacy of fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) combination in the front-line treatment for patients with advanced gastric or gastroesophageal adenocarcinoma: phase II trial.Targeted therapies for gastric cancer: current status.A phase II study of bevacizumab, oxaliplatin, and docetaxel in locally advanced and metastatic gastric and gastroesophageal junction cancers.Refining docetaxel-containing therapy for gastric cancer.Efficacy of paclitaxel-based doublet regimens combining with intraperitoneal chemotherapy for advanced gastric cancer with peritoneal metastasis.Review of docetaxel in the treatment of gastric cancer.Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study.Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis.A Phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer.A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer.Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer.A randomized phase II study of weekly docetaxel/cisplatin versus weekly docetaxel/oxaliplatin as first-line therapy for patients with advanced gastric cancer.
P2860
Q27853223-97A68923-F003-4BE4-A955-5F417116A9E4Q33405235-BF53D05D-376B-4014-BCB2-D608718AC362Q34205672-472FA2C3-C083-4071-951F-54CFA53055CDQ34307924-E28F7544-C000-4E5E-ACE5-5C094B26F295Q35445166-A98B87FF-95B2-4C07-BAE2-BE5A7ED9B712Q36411935-9418FBB9-AE94-4B15-988F-70C7DA2577B9Q37052880-0F52E15C-7BBD-4535-9213-B468FAF2973AQ38420500-27A640C6-1169-4246-8D29-E806117CE830Q41205616-6EF954E9-761B-4903-AA3C-7526424ECBFAQ43504942-9C7059E7-B043-4AA7-A8A7-ED8005B9875EQ51028375-63AE0E94-18A3-4B8C-AEF4-C97AE04C4DEEQ53803365-8D4C2E84-9FD3-44F2-BE61-CDFD96533435Q54645262-0FDF2134-78B8-4E94-B54E-741D8D7659DD
P2860
Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Phase II trial of docetaxel an ...... the gastroesophageal junction.
@ast
Phase II trial of docetaxel an ...... the gastroesophageal junction.
@en
type
label
Phase II trial of docetaxel an ...... the gastroesophageal junction.
@ast
Phase II trial of docetaxel an ...... the gastroesophageal junction.
@en
prefLabel
Phase II trial of docetaxel an ...... the gastroesophageal junction.
@ast
Phase II trial of docetaxel an ...... the gastroesophageal junction.
@en
P2093
P356
P1433
P1476
Phase II trial of docetaxel an ...... the gastroesophageal junction.
@en
P2093
D McCollum
D Richards
P304
P356
10.1093/ANNONC/MDM449
P577
2007-09-25T00:00:00Z